Activity of mesenchymal stem cells in therapies for chronic skin wound healing

Chronic or non-healing skin wounds present an ongoing challenge in advanced wound care, particularly as the number of patients increases while technology aimed at stimulating wound healing in these cases remains inefficient. Mesenchymal stem cells (MSCs) have proved to be an attractive cell type for various cell therapies due to their ability to differentiate into various cell lineages, multiple donor tissue types, and relative resilience in ex-vivo expansion, as well as immunomodulatory effects during transplants. More recently, these cells have been targeted for use in strategies to improve chronic wound healing in patients with diabetic ulcers or other stasis wounds. Here, we outline several mechanisms by which MSCs can improve healing outcomes in these cases, including reducing tissue inflammation, inducing angiogenesis in the wound bed, and reducing scarring following the repair process. Approaches to extend MSC life span in implant sites are also examined.

[1]  Xiaobing Fu,et al.  Bone marrow‐derived mesenchymal stem cell attenuates skin fibrosis development in mice , 2014, International wound journal.

[2]  H. Satoh,et al.  Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: Reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue , 2011, Journal of cellular biochemistry.

[3]  B. Seliger,et al.  The immunomodulatory capacity of mesenchymal stem cells. , 2012, Trends in molecular medicine.

[4]  M. Robson,et al.  Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double‐blind, placebo‐controlled study , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[5]  C. Chao,et al.  Hypoxic preconditioning enhances the therapeutic potential of the secretome from cultured human mesenchymal stem cells in experimental traumatic brain injury. , 2013, Clinical science.

[6]  Alan J. Waring,et al.  Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils , 1998, Antimicrobial Agents and Chemotherapy.

[7]  A. Bayés‐Genís,et al.  Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Promote Vascular Growth In Vivo , 2012, PloS one.

[8]  R. Hancock,et al.  The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses1 , 2002, The Journal of Immunology.

[9]  J. Gumulec,et al.  Cell Therapy, a New Standard in Management of Chronic Critical Limb Ischemia and Foot Ulcer , 2010, Cell transplantation.

[10]  S. E. Berry,et al.  Injection of Vessel‐Derived Stem Cells Prevents Dilated Cardiomyopathy and Promotes Angiogenesis and Endogenous Cardiac Stem Cell Proliferation in mdx/utrn−/− but Not Aged mdx Mouse Models for Duchenne Muscular Dystrophy , 2013, Stem cells translational medicine.

[11]  Benjamin M. Wu,et al.  Human mesenchymal stem cell proliferation and osteogenic differentiation in fibrin gels in vitro. , 2006, Tissue engineering.

[12]  Nance Beyer Nardi,et al.  Mesenchymal stem cells combined with an artificial dermal substitute improve repair in full-thickness skin wounds. , 2012, Burns : journal of the International Society for Burn Injuries.

[13]  Diana Whaley,et al.  The effect of multifunctional polymer-based gels on wound healing in full thickness bacteria-contaminated mouse skin wound models. , 2007, Biomaterials.

[14]  W. Keith,et al.  A Small Molecule Modulator of Prion Protein Increases Human Mesenchymal Stem Cell Lifespan, Ex Vivo Expansion, and Engraftment to Bone Marrow in NOD/SCID Mice , 2012, Stem cells.

[15]  P. Kuppusamy,et al.  Preconditioning mesenchymal stem cells with caspase inhibition and hyperoxia prior to hypoxia exposure increases cell proliferation , 2013, Journal of cellular biochemistry.

[16]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[17]  L. Fouillard,et al.  Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. , 2006, Gene expression.

[18]  Lorenzo Moroni,et al.  Endothelial Differentiation of Mesenchymal Stromal Cells , 2012, PloS one.

[19]  O. Bagasra,et al.  Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K. Ohta,et al.  Vascular Endothelial Growth Factor–Expressing Mesenchymal Stem Cell Transplantation for the Treatment of Acute Myocardial Infarction , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[21]  P. Quesenberry,et al.  Participation of bone marrow derived cells in cutaneous wound healing , 2003, Journal of cellular physiology.

[22]  Z. Ni,et al.  Hepatocyte Growth Factor Suppresses Transforming Growth Factor‐Beta‐1 and Type III Collagen in Human Primary Renal Fibroblasts , 2009, The Kaohsiung journal of medical sciences.

[23]  Shu‐hong Li,et al.  Interleukin-6 downregulation with mesenchymal stem cell differentiation results in loss of immunoprivilege , 2013, Journal of cellular and molecular medicine.

[24]  Xiaobing Fu,et al.  Mesenchymal stem cells delivered in a microsphere-based engineered skin contribute to cutaneous wound healing and sweat gland repair. , 2012, Journal of dermatological science.

[25]  D. Meldrum,et al.  IL-6 and TGF-&agr; Costimulate Mesenchymal Stem Cell Vascular Endothelial Growth Factor Production by ERK-, JNK-, and PI3K-Mediated Mechanisms , 2011, Shock.

[26]  Min Zhu,et al.  Human adipose tissue is a source of multipotent stem cells. , 2002, Molecular biology of the cell.

[27]  D J Prockop,et al.  Donor variation in the growth properties and osteogenic potential of human marrow stromal cells , 1999, Journal of cellular biochemistry.

[28]  H. Yoshikawa,et al.  Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair. , 2010, Stem cells and development.

[29]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[30]  W. Richter,et al.  Reduced chondrogenic potential of adipose tissue derived stromal cells correlates with an altered TGFβ receptor and BMP profile and is overcome by BMP‐6 , 2007, Journal of cellular physiology.

[31]  R. Diegelmann,et al.  Ability of chronic wound fluids to degrade peptide growth factors is associated with increased levels of elastase activity and diminished levels of proteinase inhibitors , 1997, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[32]  C. V. van Blitterswijk,et al.  The effect of donor variation and senescence on endothelial differentiation of human mesenchymal stromal cells. , 2013, Tissue engineering. Part A.

[33]  L. Griffith,et al.  The matrikine tenascin-C protects multipotential stromal cells/mesenchymal stem cells from death cytokines such as FasL. , 2013, Tissue engineering. Part A.

[34]  K. Atkinson,et al.  Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells. , 2008, Stem cells and development.

[35]  T. Noda,et al.  A Role for Hematopoietic Stem Cells in Promoting Angiogenesis , 2000, Cell.

[36]  Hermann Eichler,et al.  Comparative Analysis of Mesenchymal Stem Cells from Bone Marrow, Umbilical Cord Blood, or Adipose Tissue , 2006, Stem cells.

[37]  I. K. Cohen,et al.  Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. , 1996, The Journal of investigative dermatology.

[38]  G. Lisignoli,et al.  Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies , 2011, Journal of cellular biochemistry.

[39]  C. Attinger,et al.  Functional Limb Salvage in the Diabetic Patient: The Use of a Collagen Bilayer Matrix and Risk Factors for Amputation , 2011, Plastic and reconstructive surgery.

[40]  Yi Ping Liu,et al.  Transplantation of Bone Marrow-Derived Mesenchymal Stem Cells Promotes Delayed Wound Healing in Diabetic Rats , 2013, Journal of diabetes research.

[41]  J. Boateng,et al.  Wound healing dressings and drug delivery systems: a review. , 2008, Journal of pharmaceutical sciences.

[42]  Krisztián Németh,et al.  Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.

[43]  G. Naughton,et al.  A metabolically active human dermal replacement for the treatment of diabetic foot ulcers. , 2008, Artificial organs.

[44]  Min-jung Park,et al.  Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10 , 2009, Experimental & Molecular Medicine.

[45]  Alan Wells,et al.  Extracellular matrix signaling through growth factor receptors during wound healing , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[46]  Olivera Stojadinovic,et al.  PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[47]  Meijing Wang,et al.  TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanisms. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.

[48]  O. Çetinkale,et al.  Oxygen Free Radicals Impair Wound Healing in Ischemic Rat Skin , 1997, Annals of plastic surgery.

[49]  S. Böhm,et al.  Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC , 2011, Cell Communication and Signaling.

[50]  R. Weisel,et al.  Differentiation of Allogeneic Mesenchymal Stem Cells Induces Immunogenicity and Limits Their Long-Term Benefits for Myocardial Repair , 2010, Circulation.

[51]  P. Bowler,et al.  Controlling wound bioburden with a novel silver‐containing Hydrofiber® dressing , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[52]  J. Menzoian,et al.  Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. , 1997, Journal of vascular surgery.

[53]  Matthias Schäfer,et al.  Oxidative stress in normal and impaired wound repair. , 2008, Pharmacological research.

[54]  G. D. Phillips,et al.  Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor. , 1990, The Journal of trauma.

[55]  L Sedel,et al.  A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. , 2003, Biomaterials.

[56]  R. Tuan,et al.  Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation , 2007 .

[57]  G R Tobin,et al.  Physiology and healing dynamics of chronic cutaneous wounds. , 1998, American journal of surgery.

[58]  M. A. Leroux,et al.  Concise Review: Role of Mesenchymal Stem Cells in Wound Repair , 2012, Stem cells translational medicine.

[59]  Geoffrey C Gurtner,et al.  Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. , 2004, The American journal of pathology.

[60]  R. Tuan,et al.  Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation , 2007, Arthritis research & therapy.

[61]  M. Sabolinski,et al.  A bilayered living skin construct (APLIGRAF®) accelerates complete closure of hard‐to‐heal venous ulcers , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[62]  D. Greenhalgh,et al.  Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.

[63]  F. Claas,et al.  Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin from Human Placenta , 2004, Stem cells.

[64]  B. Stratmann,et al.  Autologous stem cell therapy in the treatment of limb ischaemia induced chronic tissue ulcers of diabetic foot patients , 2012, International journal of clinical practice.

[65]  F. Jacobsen,et al.  Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients , 2013, Proteomics.

[66]  E. Collard,et al.  Macrophage Dysfunction Impairs Resolution of Inflammation in the Wounds of Diabetic Mice , 2010, PloS one.

[67]  M. Gnecchi,et al.  Bone marrow-derived mesenchymal stem cells: isolation, expansion, characterization, viral transduction, and production of conditioned medium. , 2009, Methods in molecular biology.

[68]  R. Tuan,et al.  Comparison of Proliferative and Multilineage Differentiation Potential of Human Mesenchymal Stem Cells Derived from Umbilical Cord and Bone Marrow , 2007, Stem cells.

[69]  Michael Landthaler,et al.  Cytokines, chemokines and growth factors in wound healing , 2012, Journal of the European Academy of Dermatology and Venereology : JEADV.

[70]  Ji-xian Wang,et al.  Melatonin Pretreatment Improves the Survival and Function of Transplanted Mesenchymal Stem Cells after Focal Cerebral Ischemia , 2014, Cell transplantation.

[71]  R. Gamelli,et al.  Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. , 1998, The American journal of pathology.

[72]  Hung Li,et al.  Isolation and Characterization of Size‐Sieved Stem Cells from Human Bone Marrow , 2002, Stem cells.

[73]  P. Hebda,et al.  Keloid fibroblast responsiveness to epidermal growth factor and activation of downstream intracellular signaling pathways , 2004, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[74]  Thawatchai Maneerung,et al.  Impregnation of silver nanoparticles into bacterial cellulose for antimicrobial wound dressing , 2008 .

[75]  Elizabeth Simpson,et al.  Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. , 2003, Blood.

[76]  V. Falanga,et al.  Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. , 2007, Tissue engineering.

[77]  Liyong Pu,et al.  Antifibrotic effect of hepatocyte growth factor-expressing mesenchymal stem cells in small-for-size liver transplant rats. , 2010, Stem cells and development.

[78]  A. Rivera,et al.  Promotion of incisional wound repair by human mesenchymal stem cell transplantation , 2009, Experimental dermatology.

[79]  M. Raghunath,et al.  Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis. , 2013, Stem cells and development.

[80]  R. Zhao,et al.  Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. , 2008, Cell stem cell.

[81]  M. Matthay,et al.  Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL‐37 , 2010, Stem cells.

[82]  H. Shimizu,et al.  Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type1 , 2008, The Journal of Immunology.

[83]  T. Ohshima,et al.  Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. , 1999, Biochemical and biophysical research communications.

[84]  Arthur S Slutsky,et al.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.

[85]  Vivian H. Fan,et al.  Tethered Epidermal Growth Factor Provides a Survival Advantage to Mesenchymal Stem Cells , 2007, Stem cells.

[86]  C. López-Otín,et al.  Collagenase‐2 (MMP‐8) and matrilysin‐2 (MMP‐26) expression in human wounds of different etiologies , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[87]  G. Kopen,et al.  MicroSAGE Analysis of 2,353 Expressed Genes in a Single Cell‐Derived Colony of Undifferentiated Human Mesenchymal Stem Cells Reveals mRNAs of Multiple Cell Lineages , 2001, Stem cells.

[88]  T. Yamashita,et al.  Local administration of hepatocyte growth factor gene enhances the regeneration of dermis in acute incisional wounds. , 2004, The Journal of surgical research.

[89]  D. Phinney.  Functional heterogeneity of mesenchymal stem cells: Implications for cell therapy , 2012, Journal of cellular biochemistry.

[90]  Erzsebet Kokovay,et al.  Angiogenic Recruitment of Pericytes from Bone Marrow after Stroke , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[91]  E. Gherardi,et al.  Diverse and potent activities of HGF/SF in skin wound repair , 2004, The Journal of pathology.

[92]  F. Prósper,et al.  Adipose tissue-derived mesenchymal stem cells: isolation, expansion, and characterization. , 2013, Methods in molecular biology.

[93]  Gabriel Courties,et al.  IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis , 2010, PloS one.

[94]  I. Gussi,et al.  Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton’s jelly-derived mesenchymal stem cells , 2013, Stem Cell Research & Therapy.

[95]  F. Benvenuto,et al.  Human mesenchymal stem cells modulate B-cell functions. , 2006, Blood.

[96]  Paul G Scott,et al.  Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.

[97]  T. Crombleholme,et al.  Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. , 2000, Journal of pediatric surgery.

[98]  Catherine M. Verfaillie,et al.  Pluripotency of mesenchymal stem cells derived from adult marrow , 2007, Nature.

[99]  G. Evans,et al.  Advances in Wound Healing: A Review of Current Wound Healing Products , 2012, Plastic surgery international.

[100]  Andrea T. Badillo,et al.  IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. , 2008, The Journal of investigative dermatology.

[101]  D. Mevorach,et al.  Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. , 2005, Blood.

[102]  A. Boulton,et al.  The global burden of diabetic foot disease , 2005, The Lancet.

[103]  L. Moretta,et al.  Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. , 2008, Blood.

[104]  L. Griffith,et al.  Surface Tethered Epidermal Growth Factor Protects Proliferating and Differentiating Multipotential Stromal Cells from FasL‐Induced Apoptosis , 2012, Stem cells.

[105]  Liwen Chen,et al.  Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing , 2008, PloS one.

[106]  Bing Chen,et al.  Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: a double-blind, randomized, controlled trial. , 2011, Diabetes research and clinical practice.

[107]  A. Abbas,et al.  Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells , 2012, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[108]  D. Dalecki,et al.  Fibronectin matrix mimetics promote full-thickness wound repair in diabetic mice. , 2013, Tissue engineering. Part A.

[109]  L. Zangi,et al.  Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads , 2006, Bone Marrow Transplantation.

[110]  I. K. Cohen,et al.  MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers. , 1999, The Journal of surgical research.

[111]  T. Fahey,et al.  Diabetes impairs the late inflammatory response to wound healing. , 1991, The Journal of surgical research.

[112]  Tarynn M Witten,et al.  Impaired wound healing. , 2007, Clinics in dermatology.

[113]  M. Ashraf,et al.  Protein Kinase G1 α Overexpression Increases Stem Cell Survival and Cardiac Function after Myocardial Infarction , 2013, PloS one.

[114]  J. Bago,et al.  Endothelial differentiation of adipose tissue-derived mesenchymal stromal cells in glioma tumors: implications for cell-based therapy. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[115]  W. Jiang,et al.  Hepatocyte growth factor regulation: An integral part of why wounds become chronic , 2007, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.